This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Tempus Labs, Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Brandon L Mapes: Innovator in Tumor Organoid Culture
Introduction
Brandon L Mapes is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of biomedical research, particularly in the development of tumor organoid culture systems. His innovative work is aimed at enhancing the understanding of tumor biology and improving drug development processes.
Latest Patents
Brandon L Mapes holds a patent for "Tumor organoid culture compositions, systems, and methods." This patent introduces novel organoid culture media and systems designed for culturing tumor organoids. The methods outlined in the patent also include techniques for assessing the clonal diversity of these organoids, which can be utilized for tumor modeling and drug development applications. Notably, the tumor organoid culture media described is substantially free of R-spondins, such as R-spondin1.
Career Highlights
Brandon is currently associated with Tempus Labs, Inc., where he continues to advance his research in tumor organoid technology. His work is pivotal in bridging the gap between laboratory research and clinical applications, providing valuable insights into cancer treatment.
Collaborations
Brandon collaborates with talented professionals in his field, including Ameen Salahudeen and Verónica Sánchez Freire. These collaborations enhance the research environment and foster innovation in tumor organoid studies.
Conclusion
Brandon L Mapes is a distinguished inventor whose work in tumor organoid culture is paving the way for advancements in cancer research and treatment. His contributions are vital for the future of personalized medicine and drug development.